NeRRe Therapeutics’ £20 Million Series B2 Financing Round

Osborne Clarke advised NeRRe Therapeutics on the deal.The financing involved a syndicate of leading transatlantic life sciences investors led by new investor Columbus Venture Partners and…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here